Respiratorius is a research company. Today, the company is mainly focused on development of new drug candidates for the treatment of chronic obstructive pulmonary disease (COPD), asthma and cancer. Additionally, the company focuses on project development in the area of cardiovascular diseases. The company was formed in 1999 as a spin-off from Lund University. The company is based in Lund.
CEO
Chairman Of The Board
Board
2021-05-27 Delårsrapport 2021-Q1
2021-06-10 Årsstämma 2020
2021-08-06 Delårsrapport 2021-Q2
2021-11-10 Delårsrapport 2021-Q3
2022-01-15 Bokslutskommuniké 2021